Role of ubiquitin regulatory X domain‑containing protein 3B in the development of hepatocellular carcinoma (Review)

Oncol Rep. 2023 Mar;49(3):57. doi: 10.3892/or.2023.8494. Epub 2023 Feb 17.

Abstract

The majority of new cases and fatalities from hepatocellular carcinoma (HCC) occur in China; however, the overall morbidity and mortality rates are decreasing. A major risk factor due to the evolving epidemiology is improper lipid metabolism. Although investigations on aberrant lipid metabolism are numerous, there are only a limited number of studies available on proteasomal degradation processes. The degradation process is mainly involved in endoplasmic reticulum stabilization, the balance of lipid metabolism, and physiological functions of Golgi apparatus, endoplasmic reticulum, lysosomes and other organelles, however, this process has been little studied in the development of tumorigenesis. In order to provide some theoretical support for future research on ubiquitin regulatory X domain‑containing protein 3B (UBXN3B), the present review focuses on the role of UBXN3B, which is involved in the stabilization of the endoplasmic reticulum and the maintenance of lipid homeostasis, as well as in the promotion and development of non‑alcoholic fatty liver disease and HCC.

Keywords: endoplasmic reticulum; endoplasmic reticulum‑associated degradation; hepatocellular carcinoma; lipid metabolism; ubiquitin regulatory X domain‑containing protein 3B.

Publication types

  • Review

MeSH terms

  • Carcinoma, Hepatocellular* / metabolism
  • Endoplasmic Reticulum / metabolism
  • Golgi Apparatus / metabolism
  • Humans
  • Liver Neoplasms* / metabolism
  • Ubiquitin / metabolism

Substances

  • Ubiquitin

Grants and funding

The present study was supported by a Peking University International Hospital Research Grant (no. YN2022QN12).